Page 13 - N&V Winter 2019

Support for increased adoption of belimumab in the

treatment of SLE

In September 2016 belimumab (Benlysta), the first new treatment for lupus in more than
50 years, was finally approved by NICE for limited use on the NHS for certain patients living
with SLE in England and Wales.
As fewer than expected patients have been BR), LUPUS UK, NHS England and GSK suggested as contributing to the lower than
prescribed belimumab, NICE, the University have signed a joint letter addressing some anticipated uptake. Members can read the
of Manchester (acting on behalf of BILAG- of the main issues that have been letter below:

If you are having difficulty reading this letter, it can found
on our website www.lupusuk.org.uk/belimumab-in-sle or call/email National Office to request a copy.

Freedom Insurance

Providing Travel and life Insurance for Charities and their members

Most Freedom products feature a programme This involves no extra cost to the customer.
that donates part of the revenue it earns to In this way Freedom hopes to make a small
the particular charity through which the contribution to each Charity’s valuable work
business was introduced. in research and support.
Tel: 01223 454290 www.freedominsure.co.uk
268C
11
luPus uK NEWS & VIEWS SUMMER 2019